454 related articles for article (PubMed ID: 28591186)
1. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E
PLoS One; 2017; 12(6):e0179136. PubMed ID: 28591186
[TBL] [Abstract][Full Text] [Related]
2. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
[TBL] [Abstract][Full Text] [Related]
3. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
[TBL] [Abstract][Full Text] [Related]
4. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
[TBL] [Abstract][Full Text] [Related]
5. Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases.
Ino K; Nakase K; Nakamura A; Nakamori Y; Sugawara Y; Miyazaki K; Monma F; Fujieda A; Sugimoto Y; Ohishi K; Masuya M; Katayama N
Intern Med; 2017; 56(6):707-711. PubMed ID: 28321075
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.
Ota H; Yamamoto H; Kimura M; Araoka H; Fujii T; Umeyama T; Ohno H; Miyazaki Y; Kaji D; Taya Y; Nishida A; Ishiwata K; Tsuji M; Takagi S; Asano-Mori Y; Yamamoto G; Uchida N; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
Mycopathologia; 2017 Oct; 182(9-10):847-853. PubMed ID: 28577122
[TBL] [Abstract][Full Text] [Related]
7. Case of endobronchial metastasis from breast cancer accompanied with Cunninghamella bertholletiae tracheobronchial mycetoma.
Uno K; Hishiya N; Matsuda M; Kai Y; Amano M; Nakamura A; Tohjyo T; Kawaguchi T; Nakano R; Yano H; Kasahara K; Mikasa K
J Infect Chemother; 2019 Dec; 25(12):1065-1069. PubMed ID: 31227382
[TBL] [Abstract][Full Text] [Related]
8. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature.
Garey KW; Pendland SL; Huynh VT; Bunch TH; Jensen GM; Pursell KJ
Pharmacotherapy; 2001 Jul; 21(7):855-60. PubMed ID: 11444582
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
[TBL] [Abstract][Full Text] [Related]
10. Antifungal combinations in Mucorales: A microbiological perspective.
Schwarz P; Cornely OA; Dannaoui E
Mycoses; 2019 Sep; 62(9):746-760. PubMed ID: 30830980
[TBL] [Abstract][Full Text] [Related]
11. Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association.
Muggeo P; Calore E; Decembrino N; Frenos S; De Leonardis F; Colombini A; Petruzziello F; Perruccio K; Berger M; Burnelli R; Zanazzo GA; Santoro N; Cesaro S
Mycoses; 2019 Feb; 62(2):165-170. PubMed ID: 30338581
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States.
Badali H; Cañete-Gibas C; McCarthy D; Patterson H; Sanders C; David MP; Mele J; Fan H; Wiederhold NP
J Clin Microbiol; 2021 Aug; 59(9):e0123021. PubMed ID: 34232068
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B.
Shigemura T; Nakazawa Y; Matsuda K; Motobayashi M; Saito S; Koike K
Int J Infect Dis; 2014 Dec; 29():200-2. PubMed ID: 25461663
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature.
Otto WR; Pahud BA; Yin DE
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):342-350. PubMed ID: 31181136
[TBL] [Abstract][Full Text] [Related]
19. Paediatric cutaneous mucormycosis: A case report and review of the literature.
Ziaka M; Papakonstantinou E; Vasileiou E; Chorafa E; Antachopoulos C; Roilides E
Mycoses; 2022 Jul; 65(7):674-682. PubMed ID: 35514044
[TBL] [Abstract][Full Text] [Related]
20. Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.
Kontoyiannis DP; Azie N; Franks B; Horn DL
Mycoses; 2014 Apr; 57(4):240-6. PubMed ID: 24147728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
